Panagora Asset Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,628
| Closed | -$395K | – | 1219 |
|
|
2025
Q1 | $395K | Sell |
14,628
-28,945
| -66% | -$916K | ﹤0.01% | 869 |
|
|
2024
Q4 | $1.56M | Sell |
43,573
-616
| -1% | -$23K | 0.01% | 566 |
|
|
2024
Q3 | $1.68M | Buy |
44,189
+15,308
| +53% | +$629K | 0.01% | 572 |
|
|
2024
Q2 | $1.31M | Buy |
28,881
+16,999
| +143% | +$782K | 0.01% | 627 |
|
|
2024
Q1 | $576K | Buy |
+11,882
| New | +$582K | ﹤0.01% | 949 |
|
|
2021
Q3 | – | Sell |
-219
| Closed | -$22K | – | 2367 |
|
|
2021
Q2 | $22K | Sell |
219
-6,206
| -97% | -$623K | ﹤0.01% | 2160 |
|
|
2021
Q1 | $627K | Hold |
6,425
| – | – | ﹤0.01% | 1223 |
|
|
2020
Q4 | $495K | Hold |
6,425
| – | – | ﹤0.01% | 1232 |
|
|
2020
Q3 | $473K | Sell |
6,425
-406
| -6% | -$32.6K | ﹤0.01% | 1182 |
|
|
2020
Q2 | $501K | Sell |
6,831
-584
| -8% | -$45.8K | ﹤0.01% | 1204 |
|
|
2020
Q1 | $427K | Sell |
7,415
-2,290
| -24% | -$159K | ﹤0.01% | 1189 |
|
|
2019
Q4 | $762K | Sell |
9,705
-14,583
| -60% | -$1.07M | ﹤0.01% | 1158 |
|
|
2019
Q3 | $1.66M | Sell |
24,288
-248
| -1% | -$16.7K | 0.01% | 821 |
|
|
2019
Q2 | $1.95M | Sell |
24,536
-11,612
| -32% | -$921K | 0.01% | 844 |
|
|
2019
Q1 | $3.03M | Sell |
36,148
-4,176
| -10% | -$436K | 0.01% | 683 |
|
|
2018
Q4 | $4.75M | Sell |
40,324
-6,875
| -15% | -$795K | 0.02% | 475 |
|
|
2018
Q3 | $5.69M | Buy |
47,199
+28,648
| +154% | +$3.56M | 0.02% | 482 |
|
|
2018
Q2 | $2.14M | Buy |
+18,551
| New | +$2.03M | 0.01% | 846 |
|
|
2017
Q3 | – | Sell |
-924
| Closed | -$59K | – | 2493 |
|
|
2017
Q2 | $59K | Buy |
924
+468
| +103% | +$28.8K | ﹤0.01% | 2025 |
|
|
2017
Q1 | $26K | Sell |
456
-16,872
| -97% | -$1.01M | ﹤0.01% | 2119 |
|
|
2016
Q4 | $1.06M | Sell |
17,328
-606
| -3% | -$39.5K | ﹤0.01% | 1182 |
|
|
2016
Q3 | $1.24M | Sell |
17,934
-17,554
| -49% | -$1.16M | 0.01% | 1104 |
|
|
2016
Q2 | $1.98M | Sell |
35,488
-17,102
| -33% | -$1.03M | 0.01% | 871 |
|
|
2016
Q1 | $3.19M | Sell |
52,590
-71,510
| -58% | -$4.21M | 0.02% | 712 |
|
|
2015
Q4 | $7.93M | Buy |
124,100
+5,552
| +5% | +$360K | 0.04% | 425 |
|
|
2015
Q3 | $7.95M | Buy |
118,548
+20,634
| +21% | +$1.46M | 0.04% | 388 |
|
|
2015
Q2 | $6.69M | Buy |
97,914
+51,524
| +111% | +$3.27M | 0.03% | 438 |
|
|
2015
Q1 | $2.58M | Hold |
46,390
| – | – | 0.01% | 700 |
|
|
2014
Q4 | $2.38M | Sell |
46,390
-43,116
| -48% | -$2.12M | 0.01% | 689 |
|
|
2014
Q3 | $3.3M | Buy |
89,506
+27,164
| +44% | +$980K | 0.02% | 604 |
|
|
2014
Q2 | $2.44M | Buy |
62,342
+55,944
| +874% | +$2.08M | 0.01% | 742 |
|
|
2014
Q1 | $241K | Sell |
6,398
-5,610
| -47% | -$196K | ﹤0.01% | 1671 |
|
|
2013
Q4 | $454K | Sell |
12,008
-654
| -5% | -$25K | ﹤0.01% | 1421 |
|
|
2013
Q3 | $549K | Buy |
12,662
+6,192
| +96% | +$249K | ﹤0.01% | 1334 |
|
|
2013
Q2 | $234K | Buy |
+6,470
| New | +$197K | ﹤0.01% | 1554 |
|
Other funds holding USNA
Panagora Asset Management's USNA Position: Q2 2025 in Review
Panagora Asset Management sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 14,628 shares — an estimated $395K sold.
Panagora Asset Management first reported a position in USNA in Q2 2013 and held it in 35 quarters. The position peaked at $7.95M in Q3 2015. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.
- Panagora Asset Management reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
- Panagora Asset Management sold 14,628 Usana Health Sciences shares in Q2 2025, an estimated $395K.
- Panagora Asset Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 35 quarters.
- Panagora Asset Management's Usana Health Sciences position peaked at $7.95M in Q3 2015.
- 164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.
Based on Panagora Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.